RABIMEXA-IT

Description

RABIMEXA-IT contains Rabeprazole 20 mg Gastro-Resistant + Itopride 150 mg PR Capsules, a combination used for the management of selected acid-related and gastrointestinal conditions. Rabeprazole reduces stomach acid production, while Itopride supports gastrointestinal movement and gastric emptying.

In addition, the combination may help manage symptoms such as heartburn, acid reflux, bloating, fullness and upper abdominal discomfort when prescribed by a healthcare professional. Therefore, use RABIMEXA-IT according to medical advice.

Related RABIMEXA formulations:

• RABIMEXA-DSR – Rabeprazole + Domperidone Capsules
• RABIMEXA-LSR – Related Rabeprazole-based formulation
• RABIMEXA-ASR – Related Rabeprazole-based formulation

Therapeutic Segment

Gastrointestinal | Acid-Related Disorders | Proton Pump Inhibitor | Prokinetic

Uses of RABIMEXA-IT

RABIMEXA-IT may be prescribed for selected gastrointestinal conditions associated with excess stomach acid and reduced gastrointestinal motility.

It may help manage:

• Gastroesophageal reflux symptoms
• Heartburn
• Acid reflux
• Upper abdominal discomfort
• Bloating and abdominal fullness
• Indigestion associated with gastrointestinal motility problems
• Other related gastrointestinal conditions as diagnosed by a healthcare professional

However, the exact indication depends on the patient’s condition. Therefore, use this medicine only when prescribed by a qualified healthcare professional.

Key Benefits of RABIMEXA-IT

RABIMEXA-IT combines an acid-reducing medicine with a prokinetic agent.

• Contains Rabeprazole 20 mg
• Contains Itopride 150 mg
• Helps reduce excessive gastric acid production
• May help relieve heartburn and acid reflux symptoms
• Supports gastrointestinal movement
• May help improve gastric emptying
• May help reduce bloating and upper abdominal discomfort
• Convenient oral capsule formulation
• Supplied in 10 × 10 ALU-ALU packaging

Furthermore, the two ingredients work through different mechanisms. As a result, the combination may provide support when acid-related symptoms occur along with gastrointestinal motility problems.

How the Combination Works

Rabeprazole belongs to the proton pump inhibitor group. It reduces gastric acid secretion by blocking the gastric proton pump responsible for the final stage of acid production.

Meanwhile, Itopride is a prokinetic medicine. It supports gastrointestinal movement and may help improve gastric emptying. It also acts on dopamine receptors and influences acetylcholinesterase activity in the digestive tract.

Therefore, the combination can help reduce stomach acid while supporting gastrointestinal motility.

Side Effects of OverUsing RABIMEXA-IT

Some patients may experience side effects while taking this combination.

Possible effects include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea
• Constipation
• Dizziness
• Stomach discomfort
• Increased salivation

These effects may not occur in everyone. However, contact your healthcare professional if symptoms become severe, persistent or unusual.

Safety Information for RABIMEXA-IT

Use RABIMEXA-IT only according to your healthcare professional’s prescription.

Before starting treatment, tell your doctor if you:

• Have liver or kidney problems
• Have a history of gastrointestinal bleeding or obstruction
• Have an allergy to Rabeprazole, Itopride or any ingredient in the formulation
• Have a gastrointestinal condition that may be affected by increased gastric movement
• Are pregnant, planning pregnancy or breastfeeding
• Take prescription medicines, over-the-counter medicines or supplements

In addition, tell your doctor about all medicines you take because some medicines may interact with Rabeprazole or Itopride.

Do not change the prescribed dose without medical advice. Also, seek medical attention if you experience severe abdominal pain, gastrointestinal bleeding or an unusual allergic reaction.

For additional information about Rabeprazole, refer to the DailyMed Rabeprazole Drug Information.

Dosage & Administration

Take RABIMEXA-IT exactly as prescribed by your healthcare professional.

• Swallow the capsule whole with water.
• Do not crush or chew the capsule.
• Take it at the recommended time.
• Follow the prescribed dose and treatment duration.
• Do not take more than the prescribed amount.
• If you miss a dose, take it when you remember unless it is nearly time for your next dose.
• Do not take an extra dose to compensate for a missed dose.

The appropriate dose depends on the patient’s condition and response to treatment. Therefore, always follow your doctor’s instructions.

Rabeprazole 20 mg & Itopride 150 mg Information

RABIMEXA-IT combines Rabeprazole 20 mg Gastro-Resistant with Itopride 150 mg PR in a capsule formulation.

Rabeprazole helps reduce gastric acid secretion, while Itopride supports gastrointestinal movement and gastric emptying. Therefore, the combination may help manage selected acid-related and gastrointestinal motility symptoms.

The product is supplied in 10 × 10 ALU-ALU packaging.

Storage

• Store RABIMEXA-IT according to the conditions stated on the product label.
• Keep the capsules in their original packaging.
• Protect from excessive heat and moisture.
• Keep away from direct sunlight.
• Store in a cool and dry place.
• Keep out of reach of children.
• Do not use the medicine after the expiry date.
• Follow any additional storage instructions printed on the product packaging.